文献速递高血压

MESA研究:血管紧张素原水平与高血压的性别及种族差异

Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA).
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

该研究在MESA队列5786名参与者中测量血浆血管紧张素原,分析其与种族、性别、血压及高血压的关系;结果发现女性水平高于男性,不同种族间存在差异,水平升高与血压升高及高血压患病相关,且男性血压差异更大。

要点

  • 女性血管紧张素原水平显著高于男性,且不同种族间水平存在差异。
  • 血管紧张素原水平升高与血压升高及高血压患病风险增加相关。
  • 同等相对差异的血管紧张素原水平在男性中与收缩压的关联强于女性。

核心结论

  • 血管紧张素原水平存在性别和种族差异,并与血压及高血压患病正相关,且该关联在性别间不同。

研究设计与样本

  • 在MESA队列5786名参与者中测量血浆血管紧张素原水平,采用线性、逻辑回归和Cox比例风险模型分析其与血压、现患高血压及新发高血压的关联。

主要发现

  • 女性血管紧张素原水平显著高于男性,自报种族间水平从高到低依次为白人、黑人、西班牙裔和华裔。
  • 调整其他危险因素后,较高血管紧张素原水平与较高血压及现患高血压的比值比相关。
  • 在未服用RAAS阻断药物的男性中,对数血管紧张素原每增加一个标准差,收缩压高2.61 mm Hg(95% CI: 1.49-3.80)。
  • 在女性中,相同的对数血管紧张素原增量与收缩压高0.97 mm Hg相关(95% CI: 0.30-1.65)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Angiotensinogen is the proximal precursor of the angiotensin peptide hormones of the renin-angiotensin-aldosterone system (RAAS). Clinical trials are ongoing targeting angiotensinogen for the treatment of hypertension and heart failure. The epidemiology of angiotensinogen is not well defined, particularly its relationship to ethnicity, sex, and blood pressure (BP)/hypertension. OBJECTIVES: The authors sought to determine the relationship of circulating angiotensinogen levels to ethnicity, sex, BP, incident hypertension, and prevalent hypertension in a modern sex-balanced ethnically diverse cohort. METHODS: Plasma angiotensinogen levels were measured in 5,786 participants from the MESA (Multi-Ethnic Study of Atherosclerosis). Linear, logistic, and Cox proportional hazards models were utilized to examine the associations of angiotensinogen with BP, prevalent hypertension, and incident hypertension, respectively. RESULTS: Angiotensinogen levels were significantly higher in females than males and differed across self-reported ethnicities with the ordering (from highest to lowest): White, Black, Hispanic, and Chinese adults. Higher levels were associated with higher BP and odds of prevalent hypertension, after adjusting for other risk factors. Equivalent relative differences in angiotensinogen were associated with greater differences in BP in males vs females. In males not taking RAAS-blocking medications, a standard deviation increment in log-angiotensinogen was associated with 2.61 mm Hg higher systolic BP (95% CI: 1.49-3.80), while in females the same increment in angiotensinogen was associated with 0.97 mm Hg higher systolic BP (95% CI: 0.30-1.65). CONCLUSIONS: Significant differences in angiotensinogen levels are present between sexes and ethnicities. A positive association is present between levels and prevalent hypertension and BP, which differs between sexes.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Trainor PJ, Brambatti M, Carlisle SM, et al. Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2023. PMID: 36990544. doi:10.1016/j.jacc.2023.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。